User profiles for A. Borkhardt

Arndt Borkhardt

Verified email at med.uni-duesseldorf.de
Cited by 35262

MiR-125 in normal and malignant hematopoiesis

L Shaham, V Binder, N Gefen, A Borkhardt, S Izraeli - Leukemia, 2012 - nature.com
MiR-125 is a highly conserved microRNA throughout many different species from nematode
to humans. In humans, there are three homologs (hsa-miR-125b-1, hsa-miR-125b-2 and hsa…

[HTML][HTML] Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy

T Tuschl, A Borkhardt - Molecular Interventions, 2002 - triggered.edina.clockss.org
RNA interference (RNAi) represents an evolutionarily conserved cellular defense for controlling
the expression of foreign genes in most eukaryotes including humans. RNAi is triggered …

Childhood cancer predisposition syndromes—a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric …

T Ripperger, SS Bielack, A Borkhardt… - American journal of …, 2017 - Wiley Online Library
Heritable predisposition is an important cause of cancer in children and adolescents.
Although a large number of cancer predisposition genes and their associated syndromes and …

[HTML][HTML] The landscape of genomic alterations across childhood cancers

…, S Lambo, S Waszak, C Blattmann, A Borkhardt… - Nature, 2018 - nature.com
Pan-cancer analyses that examine commonalities and differences among various cancer
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …

New microRNAs from mouse and human

M Lagos-Quintana, R Rauhut, J Meyer, A Borkhardt… - Rna, 2003 - rnajournal.cshlp.org
MicroRNAs (miRNAs) represent a new class of noncoding RNAs encoded in the genomes of
plants, invertebrates, and vertebrates. MicroRNAs regulate translation and stability of target …

Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots

…, AM Ford, R Repp, A Borkhardt… - Proceedings of the …, 1997 - National Acad Sciences
Epidemiological evidence has suggested that some pediatric leukemias may be initiated in
utero and, for some pairs of identical twins with concordant leukemia, this possibility has …

Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

…, D Bhojwani, PG Schlegel, A Borkhardt… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Blinatumomab is a bispecific T-cell engager antibody construct targeting CD19 on
B-cell lymphoblasts. We evaluated the safety, pharmacokinetics, recommended dosage, and …

Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing

…, B Brors, J Felsberg, G Reifenberger, A Borkhardt… - Nature, 2014 - nature.com
Epigenetic alterations, that is, disruption of DNA methylation and chromatin architecture, are
now acknowledged as a universal feature of tumorigenesis 1 . Medulloblastoma, a clinically …

Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia

M Dördelmann, A Reiter, A Borkhardt… - Blood, The Journal …, 1999 - ashpublications.org
To define prognostic factors in infant acute lymphoblastic leukemia (ALL), the outcome of
106 infants (age ≤12 months) during 3 consecutive multicenter trials of the Berlin-Frankfurt-…

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

…, S Strehl, OA Haas, G Mann, V Binder, A Borkhardt… - The Lancet, 2008 - thelancet.com
Background Children with Down's syndrome have a greatly increased risk of acute
megakaryoblastic and acute lymphoblastic leukaemias. Acute megakaryoblastic leukaemia in …